The system aims to address underlying chronic cough and issues with mucus production and clearance in chronic bronchitis.

AirNexis Therapeutics, a clinical stage biotech company developing therapeutics for pulmonary diseases, today announced the close of a $200 million Series A financing round and the in-license of a ...

UK ex-servicewomen are significantly more likely to experience health conditions such as COPD, osteoarthritis and obesity than civilian women, according to a comprehensive new research report ...

Mount Sinai analysis looks at the effectiveness of electrocardiograms analyzed via deep learning as a tool for early COPD detection ...

"2025 was a year that demonstrated Bambusa's execution-first culture," said Dr. Xu. "With multiple clinical programs advancing in parallel, we are entering 2026 positioned to deliver up to 10 clinical ...

AirNexis has handed over $40 million cash for Haisco’s HSK39004, coded by AirNexis as AN01. Under the terms of the deal, ...

New research from the University of Vermont reveals exposure to smoke from Canadian wildfires in the summer of 2023 led to worsening asthma symptoms in children in Vermont and upstate New York.

A quasi-experimental study found anticipatory nursing in chronic obstructive pulmonary disease lowered anxiety and depression ...

Global pulmonary function testing market growth is driven by rising prevalence of chronic respiratory diseases, increasing geriatric population, and growing adoption of diagnostic monitoring ...

The rise in wildfires globally brings into sharp focus how such disasters increasingly threaten our health and security. One ...